Understanding Testosterone in Women

When it comes to hormone replacement therapy (HRT), testosterone is often overlooked or misunderstood in women’s health. While testosterone is usually associated with men, it plays a crucial role in women’s health as well. Surprisingly, women have more testosterone than estrogen by volume, yet this hormone is rarely discussed or utilized effectively. In this blog post, we’ll explore the myths and misconceptions surrounding testosterone in women, its importance, and how it can be optimally used in hormone replacement therapy.

The Misunderstood Hormone: Testosterone in Women

Testosterone is often thought of as a male hormone, but women produce it in significant amounts. In fact, when adjusted for units, a woman will have 5-10 times more testosterone than estrogen at any point in her life. However, this doesn’t necessarily mean that testosterone is the most important hormone for women. The challenge lies in identifying whether a perceived testosterone deficiency is due to adrenal dysfunction, precursor deficiency, true testosterone deficiency, or imbalances in estrogen and progesterone. This distinction is crucial because many studies on testosterone focus solely on testosterone replacement, often neglecting the broader context of hormone optimization.

In women, testosterone is produced in three main areas: the ovaries, adrenal glands, and peripheral tissues. Unlike men, where 95% of testosterone is produced in the testes, women’s testosterone production is more distributed, with 25% coming from the ovaries, 25% from the adrenal glands, and 50% from peripheral conversion of precursor hormones. This distribution is beneficial for women, especially during menopause, as 75% of their testosterone production can still continue after ovarian function declines.

The Relationship Between Androgens and Testosterone

Testosterone belongs to a group of hormones called androgens, which includes dihydrotestosterone (DHT), androstenedione, and dehydroepiandrosterone (DHEA). The terms “androgen deficiency” and “testosterone deficiency” are often used interchangeably, but it’s important to consider testosterone within the broader context of androgen deficiency. This approach opens up more treatment options than simply replacing testosterone alone.

Historically, medical research and care for women, especially in the realm of hormone replacement, have been suboptimal. The majority of research on testosterone in women has centered around Hypoactive Sexual Desire Disorder (HSDD), a psychiatric condition characterized by a lack of sexual desire or interest in sexual activity. Despite recommendations from some medical organizations for short-term testosterone therapy for HSDD, there is no commercial testosterone product available for women in the United States. This has led to a lack of adequate exploration and use of testosterone therapy in women’s health.

The Evidence for Testosterone in Women

One of the reasons testosterone is underutilized in women is the lack of awareness among physicians, many of whom are not trained in hormone replacement therapy. The Endocrine Society, a leading organization in hormone health, has historically recommended against diagnosing androgen deficiency syndrome in women due to a lack of well-defined symptoms associated with testosterone deficiency. However, this stance overlooks the broader implications of testosterone deficiency, especially in areas like bone health, muscle mass, and overall well-being.

For example, women experiencing perimenopause and postmenopause often suffer from sarcopenia (loss of muscle mass) and osteoporosis (loss of bone mass and quality), both of which are linked to androgen deficiency. Despite this, the symptoms of androgen deficiency often go unnoticed or are misattributed to other hormone imbalances. This is partly due to the lack of specific studies on testosterone therapy in women beyond sexual health.

The Benefits of Testosterone Therapy: A Look at the Research

Studies on menopause and testosterone therapy are relatively limited, but the available research provides valuable insights. One study of interest is a 2011 prospective cohort study that used the Menopause Rating Scale (MRS) to assess symptoms in 300 symptomatic women before and after testosterone therapy. This study included both premenopausal and postmenopausal women and revealed significant improvements in symptoms like mood, energy levels, and sexual function with testosterone therapy.

However, the study also highlighted the importance of using free testosterone levels, rather than total testosterone, to assess hormone status. Many women with “normal” total testosterone levels still exhibited symptoms of androgen deficiency, underscoring the need for a more nuanced approach to hormone testing and therapy.

In addition to sexual health, testosterone therapy has been shown to benefit bone health. For instance, a 2011 study on postmenopausal women treated with estradiol and testosterone pellets found significant improvements in bone mineral density (BMD) after 12 months. Another study demonstrated that the addition of testosterone to estrogen and progestin therapy resulted in superior improvements in BMD compared to estrogen and progestin alone.

Addressing Concerns About Testosterone Therapy

Despite the benefits, many women and healthcare providers are hesitant to use testosterone therapy due to concerns about side effects, particularly those related to mood changes, aggression, and breast cancer. However, the evidence suggests that these fears may be overstated.

For example, a 2003 randomized controlled trial on premenopausal women using testosterone cream showed improvements in psychological well-being and sexual self-rating, without any reports of increased aggression. Another study in 2019 on testosterone pellets found that women using testosterone had a 40% lower incidence of breast cancer compared to what would be expected in a control group. These findings suggest that testosterone may actually have a protective effect against breast cancer, particularly when used in conjunction with other hormones like estradiol and progesterone.

The Challenge of Iron Overload and Oxidative Stress

While testosterone therapy can offer significant benefits, it’s important to approach it with caution, especially in postmenopausal women who may be at risk of iron overload and oxidative stress. Testosterone can increase iron absorption, leading to excess oxidative stress, which can have negative health implications. This is why it’s essential to monitor additional biomarkers when optimizing hormones and to consider alternatives like DHEA, which may offer a safer option for androgen replacement in certain individuals.

DHEA as an Alternative to Testosterone

DHEA, a precursor hormone to testosterone, is another option for androgen replacement, though its effectiveness depends on the individual’s overall health status. Studies on DHEA are mixed, but when used in conjunction with optimized estradiol and progesterone, and as part of a comprehensive adrenal support program, DHEA can be an effective tool for improving quality of life, mood, and sexual function.

Conclusion: The Role of Testosterone in Hormone Replacement Therapy

Testosterone is an important hormone for women, but it’s not a panacea. Its role in hormone replacement therapy should be considered within the broader context of overall hormone optimization. For many women, optimizing estradiol and progesterone levels may be sufficient, but for others, addressing androgen deficiency with testosterone or DHEA may be necessary to achieve optimal health and well-being.

If HRT isn't working for you, you may need more androgens, but this needs to be determined through careful evaluation of your lab results, medical history, and symptoms. By taking a holistic approach to hormone therapy, you can achieve better outcomes and improve your quality of life.

‍